<code id='F48E687BB8'></code><style id='F48E687BB8'></style>
    • <acronym id='F48E687BB8'></acronym>
      <center id='F48E687BB8'><center id='F48E687BB8'><tfoot id='F48E687BB8'></tfoot></center><abbr id='F48E687BB8'><dir id='F48E687BB8'><tfoot id='F48E687BB8'></tfoot><noframes id='F48E687BB8'>

    • <optgroup id='F48E687BB8'><strike id='F48E687BB8'><sup id='F48E687BB8'></sup></strike><code id='F48E687BB8'></code></optgroup>
        1. <b id='F48E687BB8'><label id='F48E687BB8'><select id='F48E687BB8'><dt id='F48E687BB8'><span id='F48E687BB8'></span></dt></select></label></b><u id='F48E687BB8'></u>
          <i id='F48E687BB8'><strike id='F48E687BB8'><tt id='F48E687BB8'><pre id='F48E687BB8'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:172
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Novo Nordisk to buy Cardior, building up pipeline of heart drugs
          Novo Nordisk to buy Cardior, building up pipeline of heart drugs

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesLONDON—NovoNordisksaidMondayitwouldacquiretheGermanfirmCard

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Diabetes management: Digital health tools fall short, study says

          AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes